These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28065502)

  • 1. Neoadjuvant and adjuvant chemotherapy use in upper tract urothelial carcinoma.
    Cohen A; Kuchta K; Park S
    Urol Oncol; 2017 Jun; 35(6):322-327. PubMed ID: 28065502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
    Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
    Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Efficacy of Postoperative Adjuvant Chemotherapy for Patients with pT3N0M0 Upper Tract Urothelial Carcinoma.
    Huang YC; Chen MF; Shi CS; Shindel AW; Huang CE; Pang ST; Chuang CK; Chen CS; Chang YH; Lin WY; Ho DR; Chin CC; Kuo YH; Wu CF
    J Urol; 2015 Aug; 194(2):323-9. PubMed ID: 25796114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
    Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.
    Hellenthal NJ; Shariat SF; Margulis V; Karakiewicz PI; Roscigno M; Bolenz C; Remzi M; Weizer A; Zigeuner R; Bensalah K; Ng CK; Raman JD; Kikuchi E; Montorsi F; Oya M; Wood CG; Fernandez M; Evans CP; Koppie TM
    J Urol; 2009 Sep; 182(3):900-6. PubMed ID: 19616245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study.
    Vassilakopoulou M; de la Motte Rouge T; Colin P; Ouzzane A; Khayat D; Dimopoulos MA; Papadimitriou CA; Bamias A; Pignot G; Nouhaud FX; Hurel S; Guy L; Bigot P; Roumiguié M; Rouprêt M;
    Cancer; 2011 Dec; 117(24):5500-8. PubMed ID: 21638278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.
    Youssef RF; Shariat SF; Lotan Y; Wood CG; Sagalowsky AI; Zigeuner R; Kikuchi E; Weizer A; Raman JD; Remzi M; Kabbani W; Langner C; Guo CC; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V
    BJU Int; 2011 Oct; 108(8):1286-91. PubMed ID: 21332905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome.
    Yafi FA; Tanguay S; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Lacombe L; Chin J; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Kassouf W
    Urol Oncol; 2014 Jan; 32(1):31.e17-24. PubMed ID: 23428535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC).
    Audenet F; Yates DR; Cussenot O; Rouprêt M
    Urol Oncol; 2013 May; 31(4):407-13. PubMed ID: 20884249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Response Rates to Neoadjuvant Chemotherapy in High-Grade Upper Tract Urothelial Carcinoma.
    Meng X; Chao B; Vijay V; Silver H; Margolin EJ; Balar A; Taneja SS; Shah O; Bjurlin MA; Anderson CB; Huang WC
    Urology; 2019 Jul; 129():146-152. PubMed ID: 30930207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Analysis of Staging and Treatment Trends for Upper Tract Urothelial Carcinoma in the National Cancer Database.
    Browne BM; Stensland KD; Moynihan MJ; Canes D
    Clin Genitourin Cancer; 2018 Aug; 16(4):e743-e750. PubMed ID: 29506950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YD; Ha YS; Kim TH; Kwon TG; Byun SS; Jeh SU; Kim WJ
    J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review.
    Aziz A; Dobruch J; Hendricksen K; Kluth LA; Necchi A; Noon A; Rink M; Roghmann F; Seiler R; Gontero P; Kassouf W; Shariat SF; Xylinas E;
    World J Urol; 2017 Sep; 35(9):1401-1407. PubMed ID: 28074261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer.
    Porter MP; Kerrigan MC; Donato BM; Ramsey SD
    Urol Oncol; 2011; 29(3):252-8. PubMed ID: 19450992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience.
    Shirotake S; Kikuchi E; Tanaka N; Matsumoto K; Miyazaki Y; Kobayashi H; Ide H; Obata J; Hoshino K; Kaneko G; Hagiwara M; Kosaka T; Kanao K; Kodaira K; Hara S; Oyama M; Momma T; Miyajima A; Nakagawa K; Hasegawa S; Nakajima Y; Oya M
    J Urol; 2015 Apr; 193(4):1122-8. PubMed ID: 25444957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Kim JK; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2017 Jul; 35(7):458.e9-458.e15. PubMed ID: 28347659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
    Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of perioperative systemic chemotherapy in upper tract urothelial carcinoma.
    Gin GE; Ruel NH; Kardos SV; Sfakianos JP; Uchio E; Lau CS; Yuh BE
    Urol Oncol; 2017 May; 35(5):192-200. PubMed ID: 28041996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration.
    Necchi A; Lo Vullo S; Mariani L; Moschini M; Hendricksen K; Rink M; Sosnowski R; Dobruch J; Raman JD; Wood CG; Margulis V; Roupret M; Briganti A; Montorsi F; Xylinas E; Shariat SF;
    BJU Int; 2018 Feb; 121(2):252-259. PubMed ID: 28940605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Impact of Preoperative Anemia on Urothelial and Extraurothelial Recurrence in Patients With Upper Tract Urothelial Carcinoma.
    Milojevic B; Dzamic Z; Kajmakovic B; Durutovic O; Bumbasirevic U; Sipetic Grujicic S
    Clin Genitourin Cancer; 2015 Oct; 13(5):485-91. PubMed ID: 25920995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.